Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
ficlatuzumab (AV-299)
i
Other names:
AV-299, SCH 900105, AV299 , Ficla, SCH-900105, AV 299, SCH900105
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(2)
News
Trials
Company:
Biodesix, LG Chem, Xoma
Drug class:
c-MET inhibitor, Hepatocyte growth factor inhibitor
Related drugs:
‹
savolitinib (29)
amivantamab-vmjw (25)
tepotinib (24)
capmatinib (23)
TPX-0022 (8)
unecritinib (6)
CKD-702 (6)
LY2801653 (6)
GB263T (5)
gumarontinib (5)
WXSH0011 (5)
ARQ 197 (5)
REGN5093 (4)
MGCD265 (4)
AMG 102 (4)
envonalkib (3)
MCLA-129 (3)
ABN401 (3)
BPI-9016M (2)
HQP8361 (2)
HS-10241 (2)
S95027 (2)
APL-101 (2)
GSK1363089 (2)
DO-1 (1)
GST-HG16 (1)
JNJ-38877605 (1)
KRC-108 (1)
SGX523 (1)
SU11274 (1)
LY2875358 (1)
E7050 (1)
RG3638 (1)
AL2846 (0)
AMG 208 (0)
AMG 337 (0)
ARGX-111 (0)
ASKC202 (0)
ASLAN002 (0)
DO-2 (0)
EMD 1204831 (0)
HLX55 (0)
MRX34 (0)
PF-04217903 (0)
PHA665752 (0)
PM1080 (0)
RXDX-106 (0)
S-49076 (0)
SAIT301 (0)
SAR 125844 (0)
SPH 3348 (0)
TAVO412 (0)
DCC-2701 (0)
Ami-LC (0)
EMB-01 (0)
BMS-794833 (0)
h224G11 (0)
XL092 (0)
K-252a (1)
CLM-101 (0)
MP0250 (0)
ABT-510 (0)
savolitinib (29)
amivantamab-vmjw (25)
tepotinib (24)
capmatinib (23)
TPX-0022 (8)
unecritinib (6)
CKD-702 (6)
LY2801653 (6)
GB263T (5)
gumarontinib (5)
WXSH0011 (5)
ARQ 197 (5)
REGN5093 (4)
MGCD265 (4)
AMG 102 (4)
envonalkib (3)
MCLA-129 (3)
ABN401 (3)
BPI-9016M (2)
HQP8361 (2)
HS-10241 (2)
S95027 (2)
APL-101 (2)
GSK1363089 (2)
DO-1 (1)
GST-HG16 (1)
JNJ-38877605 (1)
KRC-108 (1)
SGX523 (1)
SU11274 (1)
LY2875358 (1)
E7050 (1)
RG3638 (1)
AL2846 (0)
AMG 208 (0)
AMG 337 (0)
ARGX-111 (0)
ASKC202 (0)
ASLAN002 (0)
DO-2 (0)
EMD 1204831 (0)
HLX55 (0)
MRX34 (0)
PF-04217903 (0)
PHA665752 (0)
PM1080 (0)
RXDX-106 (0)
S-49076 (0)
SAIT301 (0)
SAR 125844 (0)
SPH 3348 (0)
TAVO412 (0)
DCC-2701 (0)
Ami-LC (0)
EMB-01 (0)
BMS-794833 (0)
h224G11 (0)
XL092 (0)
K-252a (1)
CLM-101 (0)
MP0250 (0)
ABT-510 (0)
›
Associations
(2)
News
Trials
VERI cancer hierarchy
Reset Filters
MET elevation
Squamous Cell Carcinoma of Head and Neck
MET elevation
Squamous Cell Carcinoma of Head and Neck
cetuximab + AV-299
Resistant: C3 – Early Trials
cetuximab + AV-299
Resistant
:
C3
cetuximab + AV-299
Resistant: C3 – Early Trials
cetuximab + AV-299
Resistant
:
C3
MET overexpression
Squamous Cell Carcinoma of Head and Neck
MET overexpression
Squamous Cell Carcinoma of Head and Neck
cetuximab + AV-299
Sensitive: C3 – Early Trials
cetuximab + AV-299
Sensitive
:
C3
cetuximab + AV-299
Sensitive: C3 – Early Trials
cetuximab + AV-299
Sensitive
:
C3
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login